Mode
Text Size
Log in / Sign up

Standardized formal resuscitation training likely reduces neonatal mortality in low- and middle-income countries compared to no training or basic trainingA Simple Training Program Is Saving Newborn Lives in Poor Countries

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider implementing standardized formal resuscitation training to likely reduce early neonatal mortality in low- and middle-income countries.

This comprehensive meta-analysis synthesized data from randomized controlled trials, quasi-randomized trials, and cluster-randomized trials conducted exclusively in low- and middle-income countries (LMICs). The total sample size included 528,366 newborns across the included studies. The primary focus was on neonatal mortality, defined as death within the first 28 days of life, with specific analysis of components including mortality within 24 hours, within 7 days, and between 8 and 28 days of life. Secondary outcomes assessed included neonatal morbidity, teamwork behavior, and the acquisition and retention of knowledge and skills. The intervention of interest was standardized formal resuscitation training (SFNRT), which was compared against no formal resuscitation training, basic resuscitation training, and SFNRT plus additional components such as booster or refresher training. The follow-up period for mortality outcomes extended to the first 28 days of life.

Regarding the comparison between SFNRT and no SFNRT, the analysis included 353,527 participants for the 24-hour mortality outcome. The results indicated that SFNRT likely decreases 24-hour mortality, with a risk ratio (RR) of 0.73 (95% CI 0.66 to 0.82). For early neonatal mortality, involving 354,358 participants, SFNRT likely decreases this outcome as well, with an RR of 0.82 (95% CI 0.75 to 0.89). The certainty of evidence for these specific comparisons was moderate. However, data for neonatal mortality in the first 28 days, late neonatal mortality, and neonatal morbidities were not reported for the SFNRT versus no SFNRT comparison.

When comparing SFNRT to basic resuscitation training, the study included 3355 participants for the first 28 days mortality outcome. The evidence suggests that SFNRT may decrease mortality in the first 28 days, with an RR of 0.55 (95% CI 0.33 to 0.91). For the 24-hour mortality outcome in this comparison group of 169,331 participants, SFNRT likely decreases mortality with an RR of 0.59 (95% CI 0.51 to 0.67). Early neonatal mortality in 69,264 participants showed a likely decrease with an RR of 0.88 (95% CI 0.77 to 0.99). Conversely, for late neonatal mortality in 3274 participants, the analysis found that SFNRT may not decrease late neonatal mortality, with an RR of 0.47 (95% CI 0.20 to 1.11). The certainty of evidence for these comparisons was low.

The impact of booster training was assessed in a smaller subset of 511 participants. The evidence is very uncertain about the effect of SFNRT with boosters versus SFNRT alone on mortality in the first 28 days of life, with an RR of 1.23 (95% CI 0.46 to 3.27). Safety and tolerability data, including adverse events, serious adverse events, and discontinuations, were not reported in the included studies. The overall risk of bias of the included studies was mixed, largely due to a high risk of performance bias in all randomized controlled trials. Additionally, only a maximum of four studies provided data for each specific outcome.

Methodological limitations include the exclusive setting of LMICs, which restricts the generalizability of findings to high-income settings. The lack of reported data on neonatal morbidities and late neonatal mortality in the primary comparison group limits the scope of clinical conclusions. The very low certainty of evidence regarding booster sessions highlights the need for further research in this area. Despite these limitations, the findings suggest that implementing standardized formal resuscitation training is a viable strategy to reduce early neonatal mortality in resource-limited settings. The review had no dedicated funding, and the Cochrane review team reported no conflicts of interest.

Clinically, these results support the adoption of SFNRT over no training to improve survival within the first 24 hours and the first week of life. When upgrading from basic training, SFNRT may offer benefits for 28-day survival, though the magnitude of effect varies. The uncertain benefit of booster sessions suggests that while refresher training is often recommended, its specific impact on mortality requires further investigation. Questions remain regarding the long-term retention of skills and the specific components of training that drive these mortality reductions. Future studies should aim to report on morbidity outcomes and conduct trials in diverse geographic settings to broaden the applicability of these findings.

The Most Urgent Moments of Life

About 10% of babies need some form of help breathing at birth. Most just need gentle stimulation — a rub on the back, a little oxygen. But for some, the situation is more serious. Without trained hands and a clear protocol, a baby who could have survived may not.

For decades, resuscitation training varied widely around the world. In high-income countries, hospitals often have neonatologists (newborn specialists) and well-practiced teams. But in many low- and middle-income countries (LMICs), a rural health worker or midwife may be the only person present — and may have received only basic training or none at all.

What Formal Training Actually Changes

Basic resuscitation training tells a healthcare worker that resuscitation is possible. Standardized formal neonatal resuscitation training (SFNRT) goes further. It uses structured curricula, hands-on simulation, and skills-testing to build real competence.

Programs like Helping Babies Breathe and the Neonatal Resuscitation Program give providers a clear algorithm: evaluate the baby, open the airway, give ventilation (breathing support) if needed, escalate methodically. Providers practice on mannequins until the steps are automatic.

But here's the twist: while these programs have been widely promoted for years, the question of how much difference they actually make — with hard numbers — has been surprisingly difficult to answer.

How Skills Get Built Under Pressure

Think of delivering a baby in a low-resource setting like navigating a crisis without GPS. You know your destination, but in a chaotic moment, without rehearsed steps, you may freeze or skip critical actions.

SFNRT functions like muscle memory training. By rehearsing the same sequence dozens of times on a simulator, providers encode the steps so deeply that they can perform them correctly even under stress. The protocol becomes automatic. That automaticity is precisely what saves lives in the first few minutes after birth.

The Cochrane Collaboration — one of the most trusted bodies in evidence-based medicine — published an updated systematic review analyzing 27 studies that together involved more than 528,000 newborns. The review compared outcomes in settings where SFNRT was implemented against settings without formal training.

The numbers were consistent and striking across multiple studies and millions of births.

The Mortality Numbers That Matter

When SFNRT was compared to no formal training, it likely reduced deaths within the first 24 hours by about 27% (risk ratio 0.73). Early neonatal mortality — deaths in the first seven days — fell by about 18%.

When compared specifically to basic resuscitation training (the lower-level alternative), SFNRT likely reduced 24-hour mortality by about 41% and may reduce deaths across the full first 28 days of life by nearly half (risk ratio 0.55), though that last figure came from a single study and carries more uncertainty.

These are not small effects. In settings where neonatal death rates are high, a 27–41% reduction in early mortality means thousands of lives saved each year.

This doesn't mean SFNRT is a complete solution — but the size of the effect in these populations is hard to ignore.

Where the Evidence Is Strongest

It is worth being clear: nearly all of the studies in this review were conducted in low- and middle-income countries, where the gap between basic training and formal structured training is widest. In high-income countries, where hospitals already have well-trained teams, the additional benefit of SFNRT over existing protocols is less clear.

The review also found that adding booster or refresher training on top of SFNRT showed uncertain benefit — the evidence was too limited and varied to draw firm conclusions.

If you are a parent, caregiver, or healthcare advocate, this research is a reminder that the training of the people present at birth matters enormously. If you live in or are traveling to a region where medical infrastructure is limited, it is worth knowing whether local healthcare workers have received formal neonatal resuscitation training.

In higher-income settings, this evidence adds weight to calls for consistent, universal training standards — not just in hospitals, but for midwives, community health workers, and birth attendants everywhere.

A Few Honest Caveats

Despite analyzing over 528,000 births, each individual outcome was only reported by two to four studies — meaning the data for any single measurement was still limited. The review also found no studies reporting on longer-term outcomes like brain injury (hypoxic ischemic encephalopathy) or neurodevelopmental delays — critical outcomes that the research community has not yet adequately tracked.

The authors of this Cochrane review call for future research to fill two major gaps: data on neonatal brain injury outcomes, and evidence on whether adding refresher training improves results over time. Global health programs continue to expand SFNRT into high-mortality regions, with organizations like the WHO, UNICEF, and the American Academy of Pediatrics supporting scale-up efforts. The goal is a world where every baby born anywhere — in a hospital or a rural health post — has a trained set of hands ready to help them take their first breath.

Study Details

Study typeMeta analysis
Sample sizen = 353,527
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
RATIONALE: Approximately 10% of term newborns require resuscitation at birth. Training healthcare providers in standardised formal neonatal resuscitation training (SFNRT) programmes may improve neonatal outcomes. In the current update we focused on whether new literature confirmed our previous findings of a decrease in neonatal mortality and provided new reports of neonatal morbidity, particularly hypoxic ischaemic encephalopathy and neurodevelopmental outcomes. OBJECTIVES: To determine whether SFNRT programmes reduce neonatal mortality and morbidity, improve teamwork behaviour, or improve acquisition and retention of knowledge and skills. SEARCH METHODS: We searched CENTRAL, MEDLINE, three other databases, and two trial registers, together with reference checking, citation and errata/retractions checking, to identify studies for inclusion in the review. The latest search date was June 2025. ELIGIBILITY CRITERIA: We included randomised controlled trials (RCTs), quasi-RCTs, and cluster-RCTs in newborn infants that compared SFNRT with no SFNRT, with basic resuscitation training, or with SFNRT plus additional components such as booster (refresher) training. OUTCOMES: Our critical outcomes of interest were neonatal mortality (mortality in the first 28 days of life) and its components (mortality within 24 hours, within 7 days, and between 8 and 28 days of life) and neonatal morbidity. RISK OF BIAS: We assessed risk of bias in the included studies using the Cochrane RoB 1 tool. SYNTHESIS METHODS: We used the fixed-effect model for meta-analysis and reported risk ratio (RR), risk difference (RD), mean difference (MD), and number needed to treat for an additional beneficial outcome (NNTB) and number needed to treat for an additional harmful outcome (NNTH) (all with 95% confidence intervals (CI)). We analysed cluster-RCTs using the generic inverse-variance and the approximate analysis methods. Where this was precluded by the nature of the data, we summarised the results narratively. We used GRADE to assess the certainty of evidence for each outcome. INCLUDED STUDIES: We included a total of 27 studies (528,366 newborns) in the review. However, only a maximum of four studies provided data for each outcome. SYNTHESIS OF RESULTS: SFNRT compared to no SFNRT SFNRT likely decreases 24-hour mortality (RR 0.73, 95% CI 0.66 to 0.82; I² = 0%; 2 studies, 353,527 participants; moderate-certainty evidence) and early neonatal mortality (RR 0.82, 95% CI 0.75 to 0.89; I² = 0%; 2 studies, 354,358 participants; moderate-certainty evidence). Neonatal mortality in the first 28 days, late neonatal mortality, and neonatal morbidities were not reported. SFNRT compared to basic resuscitation training SFNRT may decrease mortality in the first 28 days (RR 0.55, 95% CI 0.33 to 0.91; I² not applicable; 1 study, 3355 participants; low-certainty evidence). SFNRT likely decreases 24-hour mortality (RR 0.59, 95% CI 0.51 to 0.67; I² = 82%; 3 studies, 169,331 participants; moderate-certainty evidence) and early neonatal mortality (RR 0.88, 95% CI 0.77 to 0.99; I² = 68%; 4 studies, 69,264 participants; moderate-certainty evidence). SFNRT may not decrease late neonatal mortality (RR 0.47, 95% CI 0.20 to 1.11; I² not applicable; 1 study, 3274 participants; low-certainty evidence). Neonatal morbidities were not reported. SFNRT compared to SFNRT with boosters The evidence is very uncertain about the effect of SFNRT with boosters on mortality in the first 28 days (RR 1.23, 95% CI 0.46 to 3.27; I² not applicable; 1 study, 511 participants; very low-certainty evidence). Twenty-four-hour mortality, early neonatal mortality, late neonatal mortality, and neonatal morbidities were not reported. The overall risk of bias of the included studies was mixed due to high risk of performance bias in all RCTs. The available studies reporting mortality outcomes were conducted exclusively in low- and middle-income countries (LMICs). AUTHORS' CONCLUSIONS: SFNRT, compared with no training, likely decreases mortality at 24 hours of life and in the first 7 days of life. SFNRT, compared with basic resuscitation training, may decrease mortality in the first 28 days of life, likely decreases mortality at 24 hours and 7 days of life, but may not decrease late neonatal mortality. The evidence is very uncertain whether SFNRT with boosters affects mortality in the first 28 days of life. This update confirms our 2015 review findings of decreased neonatal mortality, but did not identify any reports on neonatal morbidity, particularly hypoxic ischaemic encephalopathy and neurodevelopmental outcomes. FUNDING: This Cochrane review had no dedicated funding. REGISTRATION: Protocol (2011) DOI: 10.1002/14651858.CD009106. Original review (2015) DOI: 10.1002/14651858.CD009106.pub2.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.